Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted naltrexone medication and learning model for treatment of gambling dependence
2008-004102-14Phase 4Completed
- Sponsor
- National Public Health Institute of Finland
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of naltrexone in gambling disorder (GD), sponsored by National Public Health Institute of Finland. Started Jun 2008; status: completed.
02
Drugs
naltrexone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on 2008-004102-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004102-14.